Summary: Effect size—the actual magnitude of improvement—is often more important than statistical significance (p-values) for determining real-world treatment value. Large effect sizes combined with statistical significance and narrow confidence intervals indicate trustworthy, clinically important results; conversely, statistically significant results with trivial effect sizes are statistical artifacts with no practical meaning. Sample size creates confusion: huge samples produce statistical significance from tiny effects, while small samples fail to achieve significance despite large effects, making effect size the stable measure for comparing treatments across studies. Clinical significance—whether the effect size is large enough to matter practically—depends on the specific context: a 2-hour reduction in healing time may be statistically significant but clinically meaningless, while a 10-day reduction is both statistically significant and clinically important. When evaluating peptide research, always examine effect size alongside p-values, compare results across multiple independent studies seeking consistency, and prioritize studies showing large effect sizes with strong statistical evidence and precise confidence intervals over single studies with marginal p-values and trivial improvements.
This research article explains why effect size is often more important than p-values, how to interpret effect size measurements, and how to assess whether a peptide’s benefits are practically meaningful.
The Key Difference: Significance vs. Magnitude
Statistical significance and effect size answer different questions:
Statistical Significance (P-Value)
Asks: “Is there evidence this is not due to random chance?”
Answers: “Yes (p < 0.05) or No (p > 0.05)”
Depends on: sample size, effect size, and variability in data
Effect Size
Asks: “How big is the actual difference or improvement?”
Answers: With a number representing the magnitude (e.g., 15% improvement, 0.5 standard deviations)
Depends on: the actual difference between groups
Why This Matters
Imagine two studies on a healing peptide:
Study A: 10,000 participants, BPC-157 heals in 14.1 days vs. placebo 14.0 days, p = 0.01 (statistically significant)
Effect size: 0.07 days (about 1.7 hours)
Study B: 50 participants, BPC-157 heals in 10 days vs. placebo 20 days, p = 0.08 (not statistically significant)
Effect size: 10 days
Study A reached statistical significance with a trivial effect (1.7 hours). Study B failed to reach significance but showed a huge effect (10-day difference).
Which study matters more for real-world use? Clearly Study B—a 10-day difference in healing time is clinically important. The 1.7-hour difference in Study A, while statistically significant, is clinically meaningless.
Understanding Effect Size Measurements
Effect size is measured in several ways depending on the type of study.
Common Effect Size Measures
Percentage Improvement
The simplest measure.
Example: “BPC-157 improved healing by 40%”
This means: if placebo healed at 100%, BPC-157 healed at 140% faster (40% faster).
Interpretation:
- 0–5% improvement: tiny effect
- 5–15% improvement: small effect
- 15–30% improvement: medium effect
- 30%+ improvement: large effect
Cohen’s d (Standardized Effect Size)
A statistical measure comparing the difference between groups in terms of standard deviation.
Formula: (Group 1 average – Group 2 average) / standard deviation
Results:
- d = 0.2: small effect
- d = 0.5: medium effect
- d = 0.8+: large effect
Example: “BPC-157 had a Cohen’s d of 0.6 compared to placebo”
This means: the difference between BPC-157 and placebo was 0.6 standard deviations (a medium effect).
Cohen’s d is useful for comparing effects across different studies and measures.
Correlation or R-Squared
Shows how much of the outcome variation is explained by the treatment.
Example: “R² = 0.25” means the treatment explains 25% of the variation in outcomes. The remaining 75% is due to other factors.
Interpretation:
- R² = 0.01: explains 1% (tiny effect)
- R² = 0.06: explains 6% (small effect)
- R² = 0.14: explains 14% (medium effect)
- R² = 0.25+: explains 25%+ (large effect)
Relative Risk or Odds Ratio
Compares the likelihood of an outcome between groups.
Example: “People using BPC-157 are 2.5 times more likely to heal completely”
This means: BPC-157 group had 2.5 times the likelihood of complete healing compared to placebo.
Interpretation:
- Ratio = 1.0: no difference
- Ratio = 1.5: 50% higher likelihood
- Ratio = 2.0: twice the likelihood
- Ratio = 0.5: half the likelihood
Clinical Significance: Does the Effect Size Matter Practically?
Statistical significance tells you the effect is real. Effect size tells you how big it is. Clinical significance asks: does this size of effect matter in real life?
Example 1: Large Effect Size, Clearly Clinically Significant
Study: 100 people with slow healing
BPC-157 group: average healing time 10 days Placebo group: average healing time 30 days
Effect size: 20-day difference (66% faster healing)
Statistical significance: p < 0.001 (very significant)
Clinical significance: YES. A 20-day reduction in healing time is huge. This would change practice.
Example 2: Tiny Effect Size, Not Clinically Significant Despite Statistical Significance
Study: 5,000 people with slow healing
BPC-157 group: average healing time 14.2 days Placebo group: average healing time 14.0 days
Effect size: 0.2 days (4.8 hours)
Statistical significance: p = 0.001 (highly significant)
Clinical significance: NO. A 4.8-hour difference is not meaningful. No one would use BPC-157 for such a small benefit.
Despite strong statistical significance, the effect is clinically meaningless.
Example 3: Large Effect Size, But Not Statistically Significant (Due to Small Sample)
Study: 30 people with slow healing
BPC-157 group: average healing time 10 days Placebo group: average healing time 20 days
Effect size: 10-day difference (50% faster healing)
Statistical significance: p = 0.12 (not significant)
Clinical significance: PROBABLY YES. A 50% reduction in healing is huge. However, the small sample prevents statistical significance. Researchers would need a larger study to confirm.
How Sample Size Distorts the Relationship Between Effect Size and Significance
Sample size creates a confusing situation: you can find statistical significance with a tiny effect size in huge studies, and miss statistical significance with a huge effect size in small studies.
Large Sample Creates Statistical Significance from Tiny Effects
As samples grow larger, even tiny differences become statistically significant.
Example:
- Study with 100 participants: 10% improvement in BPC-157 group, p = 0.08 (not significant)
- Study with 10,000 participants: 10% improvement in BPC-157 group, p = 0.001 (highly significant)
Same effect size (10% improvement), but larger sample produces smaller p-value.
This means: in huge pharmaceutical trials with thousands of participants, tiny clinically meaningless improvements reach p < 0.05.
Small Sample Misses Statistical Significance from Large Effects
Small studies have low statistical power (low ability to detect real effects).
Example:
- Study with 20 participants: 40% improvement, p = 0.08 (not significant)
- Study with 200 participants: 40% improvement, p < 0.001 (highly significant)
Same large effect (40% improvement), but small sample fails to reach significance.
This means: important real effects can be missed in small studies.
The Lesson
Do not rely solely on p-values. Always examine effect size.
- Statistically significant p-value + tiny effect size = statistical artifact, not clinical importance
- Large effect size + non-significant p-value = possible real effect, but study too small (needs replication)
- Statistically significant p-value + large effect size = strong, trustworthy evidence
Interpreting Effect Sizes in Research Papers
When you read studies, look for effect size reporting.
Where to Find Effect Size
Usually in:
- Results section (alongside p-values)
- Tables (might be labeled “Cohen’s d,” “95% CI,” “% change”)
- Figures (shown as bars with error bars representing effect uncertainty)
What to Look For
Large effect size + small p-value + narrow confidence interval
Example: 30% improvement (95% CI: 25–35%), p = 0.001
Interpretation: Robust, trustworthy result. Large, practically important effect with strong evidence and narrow range.
Small effect size + small p-value + wide confidence interval
Example: 2% improvement (95% CI: -5–9%), p = 0.04
Interpretation: Statistically significant, but effect size is uncertain and potentially trivial. Caution needed.
Large effect size + large p-value + wide confidence interval
Example: 40% improvement (95% CI: -10–90%), p = 0.15
Interpretation: Possibly a real, large effect, but study is too small to prove it confidently. Larger replication studies needed.
Reported only p-value, no effect size or confidence interval
Red flag: The authors may be hiding a trivial effect. Ask for effect sizes before drawing conclusions.
Why Effect Size Matters More Than P-Values for Practical Decisions
For making real-world decisions about whether to use a peptide, effect size is more important than p-values.
P-Values Are Arbitrary
The p < 0.05 cutoff is historical convention, not law of nature. Some fields use 0.01 or 0.001. Different cutoffs produce different "significant" vs. "non-significant" judgments for the same data.
Effect sizes, however, are objective measures of actual improvement magnitude.
Effect Size Transfers Across Studies
A 20% improvement in one study is comparable to a 20% improvement in another study, even if they use different measures or populations.
P-values cannot be directly compared across studies—they depend on sample size, so different p-values might represent identical effects.
Clinical Decisions Depend on Effect Size
Deciding whether to use a treatment depends on whether the effect is large enough to matter:
- Is a 2% improvement worth the cost and side effects?
- Is a 30% improvement worth it?
- Is a 70% improvement worth it?
These decisions require knowing effect size, not just whether p < 0.05.
Effect Size Drives Meta-Analysis and Systematic Reviews
When researchers combine results from multiple studies (meta-analysis), they use effect sizes, not p-values.
This is because effect sizes are directly comparable, while p-values are not.
Assessing Overall Evidence: Combining P-Values, Effect Sizes, and Study Quality
To evaluate whether a treatment truly works, examine four things:
1. Study Design Quality
Randomized controlled trial beats observational study. Large sample beats small sample. Double-blind beats open-label.
2. Statistical Significance
P < 0.05 suggests the effect is real, not due to chance alone.
3. Effect Size
Is the improvement large enough to matter practically?
4. Consistency Across Studies
Do multiple independent studies reach similar conclusions? One study with p < 0.05 could be a fluke. Multiple studies showing similar effect sizes build confidence.
Interpreting Results
Scenario 1: Multiple Large RCTs Show Consistent 25% Improvement, All p < 0.001
Conclusion: Strong evidence the treatment works meaningfully.
Scenario 2: One Large RCT Shows 25% Improvement, p < 0.001, But Other Studies Show 5% or No Improvement
Conclusion: Results are inconsistent. The large effect might be due to:
- Study population differences
- Measurement differences
- Luck or bias in that one study
Need more research to clarify.
Scenario 3: Multiple Studies Show 2% Improvement, All p < 0.05 (Statistically Significant)
Conclusion: Effect is real but tiny. Practical value is limited despite statistical significance.
Scenario 4: One Small Study Shows 40% Improvement, p = 0.10 (Not Significant)
Conclusion: Effect size is large, but sample is too small for statistical proof. Promising but needs larger confirmation studies.
